Main Line Health is joining forces with L2C Partners and Early Charm Ventures to bring innovations developed by its nursing staff to commercialization, writes Paige Gross for Technical.ly.
As part of the partnership, Main Line Health Lankenau Institute for Medical Research, a nonprofit, biomedical research institute in Wynnewood, is getting a new business arm, called Lankenau Ventures.
Then, this newly formed arm will license inventions created at Lankenau Institute for Medical Research that focus on solving problems at various healthcare situations, including in the operating room and the patient’s hospital room.
Lankenau Ventures will, at first, focus on four main categories of clinical products for the healthcare market. These include hospital room and facility safety devices, software that offers electronic medical records add-on components, clinical tests, and clinical devices.
“Lankenau Ventures was formed to accelerate development and commercialization of medical inventions conceived by Main Line Health’s frontline healthcare workers,” said LIMR. “Each partner has invested in the joint venture and will derive revenue from licensing these inventions and spinning off companies.”
Currently, Lankenau Ventures is developing at least six nurse-led devices and software solutions focusing on patient care and experience.
Read more about Main Line Health and their new ventures in Technical.ly.